Work

A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome

Year: 2016

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Supportive Care in Cancer

DOI: 10.1007/s00520-016-3467-9

Authors: Aminah Jatoi, Megan E. Grudem, Travis J. Dockter, Matthew S. Block, Jose C. Villasboas, Angelina Tan, Erin Deering, Pashtoon M. Kasi, Aaron S. Mansfield, Juliana Perez Botero, Scott H. Okuno, Deanne R. Smith, Alan P. Fields

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida)

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Foundation for the National Institutes of Health, Mayo Clinic, National Cancer Institute

Awards: The pathophysiology and palliation of the paclitaxel-induced acute pain syndrome, G801478753

OpenAlex ID: W2555631900

FWCI: 0.539

Cites: 29

Cited by: 9

Related to: 10